Asawari (Asa) is a highly accomplished Medical Doctor (MBBS) with a specialization in Clinical Pathology (DPB), focusing on Transfusion, Transplants, Cellular Therapies, Gene Therapies, Lab Medicine, and Immunology. With over 20 years of leadership experience, Asa has managed projects and facilities including complex Diagnostic labs, hospitals, and facilities for Apheresis, Transfusion medicine, and Regenerative Medicine. She has successfully piloted and spearheaded labs, Cord Blood Banks, Gene and Cellular Therapy Facilities, and Companies towards success, making her a validated global expert in Cellular, tissue, and gene therapies.

Asa serves as a principal investigator, consultant, medical director, and subject matter expert for INDs, IRBs, ATMPs, Clinical Trials in Regenerative Medicine Therapies and Devices, Global Regulatory Compliance, International Quality Management Systems, cGMP, cGLP, cGTP compliance, Gap Audits, Internal and External Audits, Supplier Evaluations, and successfully executing projects internationally. She excels in evaluating technologies, managing technology transfer, conducting risk assessments and management, obtaining Accreditations and Certifications (AABB, AATB, FACT, JCI, CAP, ISO, US FDA, DCGI, MOHAP, and global regulations), and conducting Training and Medical Education as a Subject Matter Expert.

Among her career highlights, Asa has been a member of CTSCC (Cell Therapy Subsection Coordinating Committee), International Variance Committee, Quality, Cord Blood Banking, at AABB (American Association of Blood Banks) representing global experts for Cell and Gene Therapy. She has also been an international-ambassador of AABB for Cellular Therapies (Cell, Tissue, and Gene) since 2015, an advisor to Parents guide to cord blood foundation, Maryland, USA, since 2014, an advisor to Regenerative Outcomes, LLC, Nashville, TN, USA since 2018, and an International Faculty for the Stem Cell Group of India (for regulations and advocacy of stem cells in India).

Asa has been instrumental in laying down Cord Blood banking and Stem Cell Banking regulations in India associated with DCGI, ICMR India, and serves as a consultant for DHCR (Dubai Healthcare City), Dubai Health authority, Ministry of Health, UAE. She is a sought-after speaker, moderator, committee member at international conferences and meetings, and has international publications in Journals of significance. As a Medical Consultant, she provides expertise to Biotech, Pharmaceutical, and Regenerative Medicine Facilities and Companies Globally.

Kevin Kong, PharmD, serves as the COO & President of New Frontier Bio, a consumer health company dedicated to identifying, optimizing, and commercializing natural compounds for human health and longevity using biopharma and biotech principles. The company focuses on developing new molecular combinations inspired by nature, which synergistically activate our biological potential, reverse aging signs, and enhance natural health and lifespan at a cellular level. New Frontier Bio’s products are grounded in rigorous scientific, biotechnological, and pharmaceutical standards.

Kevin Kong is also a successful biotech investor, with notable returns such as Turning Point Therapeutics (20x return), and has operated and owned healthcare services companies like Rosewood Rehab.

With a background in Oncology Research from the University of California, Kevin holds a PharmD from the University of the Pacific, graduating at the age of 21. His expertise lies in Clinical Development, Regulatory Affairs, and Business Development within the Healthcare, Biotechnology, and Cosmetics industries.

Dr Naidoo is a physician scientist with a doctorate in Medicine from Yale University and biomedical engineering degrees. His 30 year history in the biosciences with significant research and publications coupled with Orthopedic Surgical training at Albert Einstein College of Medicine uniquely equips him to be a leading clinician today. 

Attention to detail and a profound understanding of how the body moves and functions over time enables Dr Naidoo to help his patients heal from their injuries, improve their quality of life and return to a lifestyle they once enjoyed.

Dr Naidoo collaborates with cutting edge pharmaceutical companies focused on cellular and regenerative medicine as a consultant and also served as Chief Medical Officer of several companies.

Dr Naidoo is an invited lecturer on cellular therapy at prestigious academic institutions worldwide and educates physicians on cellular therapy as well as host an international scientific Cellular Therapy Conference annually.

After a career teaching orthopedic surgery in NYC at Mt Sinai School of Medicine, Dr Naidoo relocated to Florida and established an orthopedic concierge practice in Palm Beach at which location he takes care of US an international patients with clinics and research labs in Hong Kong, Dubai and Abudhabi. Dr Naidoo maintains an active Research collaboration at Harvard University at the Dean center for Tick Borne diseases. Dr Naidoo is the Global Chief Medical officer of World Biotech Inc in Hong Kong and Integrative Medical Health and Wellness Clinics, USA.

Dr Naidoo is a native of South Africa and in his early years proudly served the revolutionary army of Nelson Mandela in South Africa’s struggle for Freedom